Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis

NCT00035178 is registered in ClinicalTrials.gov with Texas Biotechnology Corporation as lead sponsor.

NCT NCT00035178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00035178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis
Lead sponsor
Texas Biotechnology Corporation
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2002
Completion date
November 30, 2002
Enrollment
12
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, chronic, renal disease, end-stage